Henning R - Search Results

1

Renin inhibitory pentols showing improved enteral bioavailability.

Kleemann HW, Heitsch H, Henning R, Kramer W, Kocher W, Lerch U, Linz W, Nickel WU, Ruppert D, Urbach H, et al. Kleemann HW, et al. Among authors: henning r. J Med Chem. 1992 Feb 7;35(3):559-67. doi: 10.1021/jm00081a019. J Med Chem. 1992. PMID: 1738148

2

Renin inhibitors containing a pyridyl amino diol derived C-terminus.

Heitsch H, Henning R, Kleemann HW, Linz W, Nickel WU, Ruppert D, Urbach H, Wagner A. Heitsch H, et al. Among authors: henning r. J Med Chem. 1993 Sep 17;36(19):2788-800. doi: 10.1021/jm00071a009. J Med Chem. 1993. PMID: 8410992

3

Effects of the renin inhibitor N-[N-(3-(4-amino-1-piperidinyl-carbonyl)-2(R)-benzylpropionyl)-L- histid inyl] -(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6(2-pyridyl)-hexane-2-amide acetate in anesthetized rhesus monkeys.

Linz W, Heitsch H, Henning R, Jung W, Kleemann HW, Nickel WU, Ruppert D, Urbach H, Wagner A, Schölkens BA. Linz W, et al. Among authors: henning r. Arzneimittelforschung. 1994 Jul;44(7):815-20. Arzneimittelforschung. 1994. PMID: 7945514

4

Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.

Linz W, Henning R, Schölkens BA. Linz W, et al. Among authors: henning r. J Hypertens Suppl. 1991 Dec;9(6):S400-1. J Hypertens Suppl. 1991. PMID: 1840203 No abstract available.

5

A novel high affinity class of Ca2+ channel blockers.

Qar J, Barhanin J, Romey G, Henning R, Lerch U, Oekonomopulos R, Urbach H, Lazdunski M. Qar J, et al. Among authors: henning r. Mol Pharmacol. 1988 Apr;33(4):363-9. Mol Pharmacol. 1988. PMID: 2965787

6

Synthesis of a highly active angiotensin converting enzyme inhibitor: 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).

Teetz V, Geiger R, Henning R, Urbach H. Teetz V, et al. Among authors: henning r. Arzneimittelforschung. 1984;34(10B):1399-401. Arzneimittelforschung. 1984. PMID: 6097264

7

Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288.

Gohlke P, Schölkens B, Henning R, Urbach H, Unger T. Gohlke P, et al. Among authors: henning r. J Cardiovasc Pharmacol. 1989;14 Suppl 4:S32-6. J Cardiovasc Pharmacol. 1989. PMID: 2483426

8

Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166.

Striessnig J, Meusburger E, Grabner M, Knaus HG, Glossmann H, Kaiser J, Schölkens B, Becker R, Linz W, Henning R. Striessnig J, et al. Among authors: henning r. Naunyn Schmiedebergs Arch Pharmacol. 1988 Mar;337(3):331-40. doi: 10.1007/BF00168847. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2839780

9

Synthesis and neuroleptic activity of a series of 1-[1-(benzo-1,4-dioxan-2-ylmethyl)-4-piperidinyl]benzim idazolone derivatives.

Henning R, Lattrell R, Gerhards HJ, Leven M. Henning R, et al. J Med Chem. 1987 May;30(5):814-9. doi: 10.1021/jm00388a012. J Med Chem. 1987. PMID: 2883318

10

Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.

Windt WA, van Dokkum RP, Kluppel CA, Jeronimus-Stratingh CM, Hut F, de Zeeuw D, Henning RH. Windt WA, et al. Eur J Pharmacol. 2008 Feb 2;580(1-2):231-40. doi: 10.1016/j.ejphar.2007.10.060. Epub 2007 Oct 30. Eur J Pharmacol. 2008. PMID: 18036585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

605 results

Search Page